{"id":1048,"date":"2018-08-03T12:05:47","date_gmt":"2018-08-03T10:05:47","guid":{"rendered":"http:\/\/www.pharmin.sk\/?p=1048"},"modified":"2018-10-17T12:22:05","modified_gmt":"2018-10-17T10:22:05","slug":"zmeny-vo-vykazovani-udajov-pre-liekovu-databazu-oecd","status":"publish","type":"post","link":"https:\/\/www.pharmin.sk\/sk\/aktuality\/zmeny-vo-vykazovani-udajov-pre-liekovu-databazu-oecd\/","title":{"rendered":"ZMENY VO VYKAZOVAN\u00cd \u00daDAJOV PRE LIEKOV\u00da DATAB\u00c1ZU OECD"},"content":{"rendered":"

In\u0161tit\u00fat zdravotnej politiky dnes zverejnil dokument: ZMENY VO VYKAZOVAN\u00cd \u00daDAJOV PRE LIEKOV\u00da DATAB\u00c1ZU OECD.<\/p>\n

Ministerstvo zdravotn\u00edctva\u00a0sa v r\u00e1mci in\u00fdch opatren\u00ed venuje aj n\u00e1prave nespr\u00e1vneho vykazovaniu \u00fadajov pre potreby medzin\u00e1rodn\u00fdch porovnan\u00ed, a preto sa vytvorila pracovn\u00e1 skupina, ktorej cie\u013eom bolo overi\u0165 spr\u00e1vnos\u0165 vykazovania t\u00fdchto \u0161tatist\u00edk.<\/p>\n

Pracovn\u00e1 skupina MZ SR, NCZI, \u0160UKL a Asoci\u00e1cie inovat\u00edvneho farmaceutick\u00e9ho priemyslu\u00a0s pomocou spolo\u010dnosti Pharm-In<\/strong>\u00a0zanalyzovali vykazovanie liekov a spr\u00e1vne pridelili a\/alebo doplnili hodnoty DDD ku k\u00f3dom liekov v nadv\u00e4znosti na ich individu\u00e1lnu liekov\u00fa formu a sp\u00f4sob podania lieku v s\u00falade s ATC k\u00f3dmi a DDD definovan\u00fdmi WHO.<\/p>\n

NA D\u00c1TACH N\u00c1M Z\u00c1LE\u017d\u00cd.\u00a0RADI SME POMOHLI!<\/strong><\/p>\n

Kompletn\u00fd dokument si m\u00f4\u017eete stiahnu\u0165 tu:<\/p>\n

http:\/\/www.health.gov.sk\/Zdroje?\/Sources\/dokumenty\/IZP\/2017\/Spotreba-lieky-OECD-jul-2018.pdf<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

In\u0161tit\u00fat zdravotnej politiky dnes zverejnil dokument: ZMENY VO VYKAZOVAN\u00cd \u00daDAJOV PRE LIEKOV\u00da DATAB\u00c1ZU OECD. Ministerstvo zdravotn\u00edctva\u00a0sa v r\u00e1mci in\u00fdch opatren\u00ed venuje aj n\u00e1prave nespr\u00e1vneho vykazovaniu \u00fadajov pre potreby medzin\u00e1rodn\u00fdch porovnan\u00ed, a preto sa vytvorila pracovn\u00e1 skupina, ktorej cie\u013eom bolo overi\u0165 spr\u00e1vnos\u0165 vykazovania t\u00fdchto \u0161tatist\u00edk. Pracovn\u00e1 skupina MZ SR, NCZI, \u0160UKL a Asoci\u00e1cie inovat\u00edvneho farmaceutick\u00e9ho priemyslu\u00a0s<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1048","post","type-post","status-publish","format-standard","hentry","category-aktuality"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/posts\/1048","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/comments?post=1048"}],"version-history":[{"count":0,"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/posts\/1048\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/media?parent=1048"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/categories?post=1048"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/tags?post=1048"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}